Dalahay, Gemma D.
HRN: 21-50-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2024
CEFUROXIME 500MG (TAB)
05/23/2024
05/30/2024
PO
500mg Tab
BID
S/P NSVD With RMLE And Repair;
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes